An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.
Jeff L. Garwin
Advertisement
Jeff L. Garwin, PhD, MD, is associate clinical science director, Strategic Development Consulting, at PPD, part of Thermo Fisher Scientific.
Articles by Jeff L. Garwin
An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.
Advertisement
Latest Updated Articles
Exploring an Intelligent Drug Development ParadigmPublished: August 2nd 2023 | Updated:
- An Intelligent Drug Development Paradigm
Published: August 3rd 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Sustainability and Stability in Excipients
4
Centralizing AI Strategy, Ensuring Process Integrity, and Balancing Quick Wins with Long-Term Drug Design in Bio/pharma
5
